NKX2-2 and neoplasm: Moreover, there was no significant correlation between NKX2.2 methylation and clinicopathological parameters, such as sex, age, tumor differentiation, TNM stage, CEA, CA199, and fecal occult blood (p > 0.05, Table 1).